Individual risk assessment of thrombosis in pregnancy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 81, Issue 5, 2002, Pages 412-

  Lindqvist, P G ^a   Kublikas, M ^b   Dahlback B ^c  

^a Division of Obstetrics and Gynecology   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Cesarean section; Logistic regression analysis; Overweight; Prevalence of risk factors; Risk estimation in pregnancy; Thrombophilia; Thrombosis heredity

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ACTIVATED PROTEIN C RESISTANCE; ARTICLE; CALCULATION; CESAREAN SECTION; COHORT ANALYSIS; FEMALE; HEREDITY; HIGH RISK PATIENT; HUMAN; INTERNET; LOGISTIC REGRESSION ANALYSIS; MATERNAL MORTALITY; OBESITY; PARITY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; RISK; RISK ASSESSMENT; SMOKING; THROMBOEMBOLISM; THROMBOSIS;

EID: 0036093454     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2002.810507.x     Document Type: Article

References (16)

1. Maternal mortality in Sweden, 1980-88
2. Maternal mortality in the United States, 1979-86
3. Thrombotic risk during pregnancy - A population study
4. Venous thromboembolic disease in obstetrics and gynaecology: The Scottish experience
5. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen
6. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
7. Activated protein C resistance (FV.Q506) and pregnancy
8. Thrombophilia as a multigenic disease
9. The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
10. Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis?
11. Recurrence of venous thromboembolic disease and use of oral contraceptives
12. Venous thromboembolic disease in pregnancy
13. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin
14. Bleeding complications associated with low molecular weight heparin prophylaxis during pregnancy
15. Heparin and low-molecular-weight heparin. Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety